Alyssa Steimle

6PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2026
Circulating Tumor DNA (ctDNA) Clearance After Immune Checkpoint Inhibition (ICI) with Radiotherapy (RT) as a Prognostic Biomarker for Advanced Melanoma.

|May 27, 2026
Organoid Level Assessments of Human Primary and Metastatic Colorectal Cancer-Derived Organoids Predict Response to Chemotherapy and Chemoradiation.

|Feb 13, 2026
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma.

Vincent T Ma, Alice Y Zhou, Amir Forati

|Jul 10, 2025
BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer.

Rebecca A DeStefanis, Alexa E Schmitz, Alyssa K Steimle

|Jul 09, 2025
ctDNA Dynamics Identifies Pseudoprogression in a Metastatic Melanoma Patient Treated With Nivolumab/Relatlimab.

Alyssa K Steimle, Steve Y Cho, Nandakumar Menon

|Sep 14, 2024
Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil.

Alyssa K DeZeeuw, Michael F Bassetti, Evie H Carchman

Pageof 1

Frequent Collaborators

3 joint publications

Vincent T Ma

2 joint publications

Evie H Carchman

2 joint publications

Alexander Birbrair

2 joint publications

Amir M Forati